DOSSIER · 13F Holders · Q1 2026Healthcare · In Vitro & In Vivo Diagnostic SubstancesDefensive growthQuality
MYGN
MYRIAD GENETICS INC
214 institutions still hold MYRIAD GENETICS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 62855J104·In Vitro & In Vivo Diagnostic Substances·214 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
214 institutions reported MYGN in Q1 2026. ORBIMED ADVISORS LLC leads at 30.5% of the visible book. -24 net institutions QoQ — distribution reading.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 11
194 more holders available. Log in →